Tuesday, June 19, 2018
Company News: Page (1) of 1 - 09/13/17 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
New England Journal Of Medicine Publishes Data From Phase 3 inTandem3 Study Of Sotagliflozin In Patients With Type 1 Diabetes
InTandem3 Data Presented in Oral Symposium at EASD 2017Statistically Significant Benefit Seen on Primary and All Secondary MeasuresResults Support a Novel Drug Profile as a Dual SGLT1 and SGLT2 Inhibi...
(September 13, 2017)
This article is no longer available,but here are some related topics.

Page: 1

Related Keywords:England,USA,Medicine,Diet,Disease,Surgery,Medication,Childrens Health,Children,Science,Lifestyle,Medical,Genetics,Science,england,Adults,Other,
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter

Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines